#ChronicPain: Automatic establishment of a chronic pain cohort from social media using machine learning for studying opioid-alternative therapies

Abstract

Due to the high economic and public health burden of chronic pain, and the risk of public health consequences of opioid-based treatments, there is a need to identify effective alternative therapies. The evidence basis for many alternative therapies is weak or nonexistent. Social media presents a unique opportunity to gather large-scale knowledge about such therapies self-reported by sufferers themselves. We attempted to (i) verify the presence of largescale chronic pain-related chatter on Twitter, (ii) develop natural language processing (NLP) and machine learning for automatically detecting chronic pain sufferers, and (iii) identify the types of chronic pain-related information reported by them. We collected data from Twitter using chronic pain-related hashtags and keywords. We manually performed binary annotation of a sample of 4998 posts to indicate if they were self-reports of chronic pain experiences or not, and obtained inter-annotator agreement of 0.82 (Cohen's kappa). We trained and evaluated several state-of-the-art transformer-based text classification models using the annotated data. The RoBERTa model outperformed all others (F1 score = 0.84; 95% CI: 0.80-0.89), and we used this model to classify a large number of unlabeled posts. We identified 22,795 self-reported chronic pain sufferers and collected their past posted data. Via manual and NLP-driven analyses, we found information about but not limited to alternative treatments, sufferers' sentiments about treatments, side effects, and self-management strategies. Our social media-based approach will result in an automatically growing massive cohort over time, and the data can be leveraged to identify self-reported effective alternative therapies for diverse chronic pain types.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Research reported in this publication was supported in part by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) under award number R01DA046619. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH/NIDA.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

留言 (0)

沒有登入
gif